{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:35:23Z","timestamp":1790411723785,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:00:00Z","timestamp":1478044800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00592-016-0931-4","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T01:02:29Z","timestamp":1478048549000},"page":"111-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol\u2013diabetes connection? A systematic review of literature"],"prefix":"10.1007","volume":"54","author":[{"given":"Davide","family":"Noto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Arca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Tarugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo B.","family":"Cefal\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo M.","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio R.","family":"Averna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,2]]},"reference":[{"issue":"9131","key":"931_CR1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352(9131):837\u2013853","journal-title":"Lancet"},{"issue":"9607","key":"931_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","volume":"371","author":"PM Kearney","year":"2008","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaborators, Kearney PM, Blackwell L, Collins R, Keech A, Simes J, Peto R, Armitage J, Baigent C (2008) Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371(9607):117\u2013125","journal-title":"Lancet"},{"issue":"9716","key":"931_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"375","author":"N Sattar","year":"2010","unstructured":"Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375(9716):735\u2013742. doi: 10.1016\/S0140-6736(09)61965-6","journal-title":"Lancet"},{"key":"931_CR4","doi-asserted-by":"publisher","unstructured":"Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, Sofat R, Stender S, Johnson PC, Scott RA, Leusink M, Verweij N, Sharp SJ, Guo Y, Giambartolomei C, Chung C, Peasey A, Amuzu A, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Li YR, Lowe G, Gallacher J, Stewart MC, Tzoulaki I, Buxbaum SG, van der A DL, Forouhi NG, Onland-Moret NC, van der Schouw YT, Schnabel RB, Hubacek JA, Kubinova R, Baceviciene M, Tamosiunas A, Pajak A, Topor-Madry R, Stepaniak U, Malyutina S, Baldassarre D, Sennblad B, Tremoli E, de Faire U, Veglia F, Ford I, Jukema JW, Westendorp RG, de Borst GJ, de Jong PA, Algra A, Spiering W, Maitland-van der Zee AH, Klungel OH, de Boer A, Doevendans PA, Eaton CB, Robinson JG, Duggan D; DIAGRAM Consortium; MAGIC Consortium; InterAct Consortium, Kjekshus J, Downs JR, Gotto AM, Keech AC, Marchioli R, Tognoni G, Sever PS, Poulter NR, Waters DD, Pedersen TR, Amarenco P, Nakamura H, McMurray JJ, Lewsey JD, Chasman DI, Ridker PM, Maggioni AP, Tavazzi L, Ray KK, Seshasai SR, Manson JE, Price JF, Whincup PH, Morris RW, Lawlor DA, Smith GD, Ben-Shlomo Y, Schreiner PJ, Fornage M, Siscovick DS, Cushman M, Kumari M, Wareham NJ, Verschuren WM, Redline S, Patel SR, Whittaker JC, Hamsten A, Delaney JA, Dale C, Gaunt TR, Wong A, Kuh D, Hardy R, Kathiresan S, Castillo BA, van der Harst P, Brunner EJ, Tybjaerg-Hansen A, Marmot MG, Krauss RM, Tsai M, Coresh J, Hoogeveen RC, Psaty BM, Lange LA, Hakonarson H, Dudbridge F, Humphries SE, Talmud PJ, Kivim\u00e4ki M, Timpson NJ, Langenberg C, Asselbergs FW, Voevoda M, Bobak M, Pikhart H, Wilson JG, Reiner AP, Keating BJ, Hingorani AD, Sattar N (2015). HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet 385(9965):351\u2013361. doi: 10.1016\/S0140-6736(14)61183-1","DOI":"10.1016\/S0140-6736(14)61183-1"},{"key":"931_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/2050312115605518","author":"RD Beckett","year":"2015","unstructured":"Beckett RD, Schepers SM, Gordon SK (2015) Risk of new-onset diabetes associated with statin use. SAGE Open Med. doi: 10.1177\/2050312115605518","journal-title":"SAGE Open Med"},{"issue":"10","key":"931_CR6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.2015.1206","volume":"313","author":"J Besseling","year":"2015","unstructured":"Besseling J, Kastelein JJ, Defesche JC, Hutten BA, Hovingh GK (2015) Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. JAMA 313(10):1029\u20131036","journal-title":"JAMA"},{"issue":"2","key":"931_CR7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","volume":"34","author":"M Abifadel","year":"2003","unstructured":"Abifadel M, Varret M, Rab\u00e8s JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derr\u00e9 A, Vill\u00e9ger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34(2):154\u2013156","journal-title":"Nat Genet"},{"issue":"12","key":"931_CR8","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1194\/jlr.P039875","volume":"54","author":"I Minicocci","year":"2013","unstructured":"Minicocci I, Santini S, Cantisani V, Stitziel N, Kathiresan S, Arroyo JA, Mart\u00ed G, Pisciotta L, Noto D, Cefal\u00f9 AB, Maranghi M, Labbadia G, Pigna G, Pannozzo F, Ceci F, Ciociola E, Bertolini S, Calandra S, Tarugi P, Averna M, Arca M (2013) Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. J Lipid Res 54(12):3481\u20133490","journal-title":"J Lipid Res"},{"key":"931_CR9","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349:g7647","journal-title":"BMJ"},{"issue":"1","key":"931_CR10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.atherosclerosis.2007.03.005","volume":"197","author":"D Noto","year":"2008","unstructured":"Noto D, Barbagallo CM, Cefal\u00f9 AB, Falletta A, Sapienza M, Cavera G, Amato S, Pagano M, Maggiore M, Carroccio A, Notarbartolo A, Averna MR (2008) The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15\u00a0years follow-up in a Mediterranean population. Atherosclerosis 197(1):147\u2013153","journal-title":"Atherosclerosis"},{"issue":"2","key":"931_CR11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00592-011-0305-x","volume":"49","author":"D Noto","year":"2012","unstructured":"Noto D, Cefal\u00f9 AB, Barbagallo CM, Falletta A, Ganci A, Sapienza M, Cavera G, Nardi I, Pagano M, Notarbartolo A, Averna MR (2012) Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study. Acta Diabetol 49(2):145\u2013151","journal-title":"Acta Diabetol"},{"issue":"2","key":"931_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2007.05.003","volume":"195","author":"P Tarugi","year":"2007","unstructured":"Tarugi P, Averna M, Di Leo E, Cefal\u00f9 AB, Noto D, Magnolo L, Cattin L, Bertolini S, Calandra S (2007) Molecular diagnosis of hypobetalipoproteinemia: an ENID review. Atherosclerosis 195(2):19\u201327","journal-title":"Atherosclerosis"},{"issue":"33","key":"931_CR13","doi-asserted-by":"crossref","first-page":"24270","DOI":"10.1074\/jbc.M702442200","volume":"282","author":"JR Burnett","year":"2007","unstructured":"Burnett JR, Zhong S, Jiang ZG, Hooper AJ, Fisher EA, McLeod RS, Zhao Y, Barrett PH, Hegele RA, van Bockxmeer FM, Zhang H, Vance DE, McKnight CJ, Yao Z (2007) Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia. J Biol Chem 282(33):24270\u201324283","journal-title":"J Biol Chem"},{"issue":"1","key":"931_CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2009.01.037","volume":"206","author":"D Noto","year":"2009","unstructured":"Noto D, Cefal\u00f9 AB, Cannizzaro A, Min\u00e0 M, Fayer F, Valenti V, Barbagallo CM, Tuttolomondo A, Pinto A, Scium\u00e8 C, Licata G, Averna M (2009) Familial hypobetalipoproteinemia due to apolipoprotein B R463\u00a0W mutation causes intestinal fat accumulation and low postprandial lipemia. Atherosclerosis 206(1):193\u2013198","journal-title":"Atherosclerosis"},{"issue":"3","key":"931_CR15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","volume":"79","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Tuakli-Wosornu Y, Lagace TA, Kinch L, Grishin NV, Horton JD, Cohen JC, Hobbs HH (2006) Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am J Hum Genet 79(3):514\u2013523","journal-title":"Am J Hum Genet"},{"issue":"3","key":"931_CR16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.ATV.0000255311.26383.2f","volume":"27","author":"T Fasano","year":"2007","unstructured":"Fasano T, Cefal\u00f9 AB, Di Leo E, Noto D, Pollaccia D, Bocchi L, Valenti V, Bonardi R, Guardamagna O, Averna M, Tarugi P (2007) A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol. Arterioscler Thromb Vasc Biol 27(3):677\u2013681","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"931_CR17","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jhep.2014.05.023","volume":"61","author":"M Filippo Di","year":"2014","unstructured":"Di Filippo M, Moulin P, Roy P, Samson-Bouma ME, Collardeau-Frachon S, Chebel-Dumont S, Peretti N, Dumortier J, Zoulim F, Fontanges T, Parini R, Rigoldi M, Furlan F, Mancini G, Bonnefont-Rousselot D, Bruckert E, Schmitz J, Scoazec JY, Charri\u00e8re S, Villar-Fimbel S, Gottrand F, Dubern B, Doummar D, Joly F, Liard-Meillon ME, Lachaux A, Sassolas A (2014) Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia. J Hepatol 61(4):891\u2013902","journal-title":"J Hepatol"},{"issue":"5","key":"931_CR18","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1194\/jlr.M300508-JLR200","volume":"45","author":"T Tanoli","year":"2004","unstructured":"Tanoli T, Yue P, Yablonskiy D, Schonfeld G (2004) Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. J Lipid Res 45(5):941\u2013947","journal-title":"J Lipid Res"},{"issue":"4","key":"931_CR19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0016-5085(96)70082-3","volume":"111","author":"P Tarugi","year":"1996","unstructured":"Tarugi P, Lonardo A, Ballarini G, Grisendi A, Pulvirenti M, Bagni A, Calandra S (1996) Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B. Gastroenterology 111(4):1125\u20131133","journal-title":"Gastroenterology"},{"issue":"9","key":"931_CR20","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/01.ATV.0000176191.64314.07","volume":"25","author":"RR Sankatsing","year":"2005","unstructured":"Sankatsing RR, Fouchier SW, de Haan S, Hutten BA, de Groot E, Kastelein JJ, Stroes ES (2005) Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol 25(9):1979\u20131984","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"931_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0168-8278(00)80270-6","volume":"33","author":"P Tarugi","year":"2000","unstructured":"Tarugi P, Lonardo A, Ballarini G, Erspamer L, Tondelli E, Bertolini S, Calandra S (2000) A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (APO B-54.5). J Hepatol 33(3):361\u2013370","journal-title":"J Hepatol"},{"issue":"1\u20132","key":"931_CR22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cca.2008.09.021","volume":"399","author":"S Katsuda","year":"2009","unstructured":"Katsuda S, Kawashiri MA, Inazu A, Tada H, Tsuchida M, Kaneko Y, Nozue T, Nohara A, Okada T, Kobayashi J, Michishita I, Mabuchi H, Yamagishi M (2009) Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia. Clin Chim Acta 399(1\u20132):64\u201368","journal-title":"Clin Chim Acta"},{"issue":"3","key":"931_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MOL.0000000000000072","volume":"25","author":"FK Welty","year":"2014","unstructured":"Welty FK (2014) Hypobetalipoproteinemia and abetalipoproteinemia. Curr Opin Lipidol 25(3):161\u2013168","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"931_CR24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000339761","volume":"6","author":"MC Lam","year":"2012","unstructured":"Lam MC, Singham J, Hegele RA, Riazy M, Hiob MA, Francis G, Steinbrecher UP (2012) Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis. Case Rep Gastroenterol 6(2):429\u2013437","journal-title":"Case Rep Gastroenterol"},{"issue":"1","key":"931_CR25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1373\/clinchem.2004.037978","volume":"51","author":"AJ Whitfield","year":"2005","unstructured":"Whitfield AJ, Barrett PH, Robertson K, Havlat MF, van Bockxmeer FM, Burnett JR (2005) Liver dysfunction and steatosis in familial hypobetalipoproteinemia. Clin Chem 51(1):266\u2013269","journal-title":"Clin Chem"},{"key":"931_CR26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cca.2013.03.004","volume":"421","author":"LV Heeks","year":"2013","unstructured":"Heeks LV, Hooper AJ, Adams LA, Robbins P, Barrett PH, van Bockxmeer FM, Burnett JR (2013) Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343\u00a0V familial hypobetalipoproteinaemia. Clin Chim Acta 421:121\u2013125","journal-title":"Clin Chim Acta"},{"issue":"8","key":"931_CR27","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/ATVBAHA.112.301101","volume":"33","author":"AB Cefal\u00f9","year":"2013","unstructured":"Cefal\u00f9 AB, Pirruccello JP, Noto D, Gabriel S, Valenti V, Gupta N, Spina R, Tarugi P, Kathiresan S, Averna MR (2013) A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia. Arterioscler Thromb Vasc Biol 33(8):2021\u20132025","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"931_CR28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MEG.0b013e3282ffd9f8","volume":"21","author":"D Bonnefont-Rousselot","year":"2009","unstructured":"Bonnefont-Rousselot D, Condat B, Sassolas A, Chebel S, Bittar R, Federspiel MC, Cazals-Hatem D, Bruckert E (2009) Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B. Eur J Gastroenterol Hepatol 21(1):104\u2013108","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"931_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2265.2012.04498.x","volume":"79","author":"C Della Corte","year":"2013","unstructured":"Della Corte C, Fintini D, Giordano U, Cappa M, Brufani C, Majo F, Mennini C, Nobili V (2013) Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology. Clin Endocrinol (Oxf) 79(1):49\u201354","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"931_CR30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2010.03.039","volume":"139","author":"A Amaro","year":"2010","unstructured":"Amaro A, Fabbrini E, Kars M, Yue P, Schechtman K, Schonfeld G, Klein S (2010) Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. Gastroenterology 139(1):149\u2013153","journal-title":"Gastroenterology"},{"issue":"8","key":"931_CR31","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00125-011-2157-x","volume":"54","author":"ME Visser","year":"2011","unstructured":"Visser ME, Lammers NM, Nederveen AJ, van der Graaf M, Heerschap A, Ackermans MT, Sauerwein HP, Stroes ES, Serlie MJ (2011) Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia. Diabetologia 54(8):2113\u20132121","journal-title":"Diabetologia"},{"issue":"23","key":"931_CR32","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","volume":"363","author":"K Musunuru","year":"2010","unstructured":"Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, Sougnez C, Garimella KV, Fisher S, Abreu J, Barry AJ, Fennell T, Banks E, Ambrogio L, Cibulskis K, Kernytsky A, Gonzalez E, Rudzicz N, Engert JC, DePristo MA, Daly MJ, Cohen JC, Hobbs HH, Altshuler D, Schonfeld G, Gabriel SB, Yue P, Kathiresan S (2010) Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med 363(23):2220\u20132227","journal-title":"N Engl J Med"},{"issue":"3","key":"931_CR33","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/ATVBAHA.111.238766","volume":"32","author":"D Noto","year":"2012","unstructured":"Noto D, Cefal\u00f9 AB, Valenti V, Fayer F, Pinotti E, Ditta M, Spina R, Vigna G, Yue P, Kathiresan S, Tarugi P, Averna MR (2012) Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia. Arterioscler Thromb Vasc Biol 32(3):805\u2013809","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"931_CR34","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbalip.2011.10.010","volume":"1821","author":"F Mattijssen","year":"2012","unstructured":"Mattijssen F, Kersten S (2012) Regulation of triglyceride metabolism by Angiopoietin-like proteins. Biochim Biophys Acta 1821(5):782\u2013789","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"931_CR35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bbrc.2004.03.151","volume":"317","author":"K Inukai","year":"2004","unstructured":"Inukai K, Nakashima Y, Watanabe M, Kurihara S, Awata T, Katagiri H, Oka Y, Katayama S (2004) ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states. Biochem Biophys Res Commun 317(4):1075\u20131079","journal-title":"Biochem Biophys Res Commun"},{"issue":"48","key":"931_CR36","doi-asserted-by":"crossref","first-page":"19751","DOI":"10.1073\/pnas.1217552109","volume":"109","author":"F Quagliarini","year":"2012","unstructured":"Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, Boerwinkle E, Valenzuela DM, Murphy AJ, Cohen JC, Hobbs HH (2012) Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci USA 109(48):19751\u201319756","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"931_CR37","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1210\/en.2005-0476","volume":"146","author":"A K\u00f6ster","year":"2005","unstructured":"K\u00f6ster A, Chao YB, Mosior M, Ford A, Gonzalez-DeWhitt PA, Hale JE, Li D, Qiu Y, Fraser CC, Yang DD, Heuer JG, Jaskunas SR, Eacho P (2005) Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146(11):4943\u20134950","journal-title":"Endocrinology"},{"issue":"2","key":"931_CR38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng814","volume":"30","author":"R Koishi","year":"2002","unstructured":"Koishi R, Ando Y, Ono M, Shimamura M, Yasumo H, Fujiwara T, Horikoshi H, Furukawa H (2002) Angptl3 regulates lipid metabolism in mice. Nat Genet 30(2):151\u2013157","journal-title":"Nat Genet"},{"issue":"5","key":"931_CR39","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/ATVBAHA.113.302802","volume":"34","author":"N Mehta","year":"2014","unstructured":"Mehta N, Qamar A, Qu L, Qasim AN, Mehta NN, Reilly MP, Rader DJ (2014) Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits. Arterioscler Thromb Vasc Biol 34(5):1057\u20131063","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"931_CR40","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1194\/jlr.M054882","volume":"56","author":"Y Wang","year":"2015","unstructured":"Wang Y, Gusarova V, Banfi S, Gromada J, Cohen JC, Hobbs HH (2015) Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion. J Lipid Res 56(7):1296\u20131307","journal-title":"J Lipid Res"},{"issue":"7","key":"931_CR41","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.113.301397","volume":"33","author":"MR Robciuc","year":"2013","unstructured":"Robciuc MR, Maranghi M, Lahikainen A, Rader D, Bensadoun A, \u00d6\u00f6rni K, Metso J, Minicocci I, Ciociola E, Ceci F, Montali A, Arca M, Ehnholm C, Jauhiainen M (2013) Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler Thromb Vasc Biol 33(7):1706\u20131713","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"931_CR42","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.atherosclerosis.2015.02.031","volume":"239","author":"X Wang","year":"2015","unstructured":"Wang X, Wang D, Shan Z (2015) Clinical and genetic analysis of a family diagnosed with familial hypobetalipoproteinemia in which the proband was diagnosed with diabetes mellitus. Atherosclerosis 239(2):552\u2013556","journal-title":"Atherosclerosis"},{"key":"931_CR43","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Investig 109:1125\u20131131","journal-title":"J Clin Investig"},{"issue":"6","key":"931_CR44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(01)00010-8","volume":"40","author":"H Shimano","year":"2001","unstructured":"Shimano H (2001) Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40(6):439\u2013452","journal-title":"Prog Lipid Res"},{"issue":"6","key":"931_CR45","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1194\/jlr.M900274-JLR200","volume":"51","author":"C Pramfalk","year":"2010","unstructured":"Pramfalk C, Jiang ZY, Cai Q, Hu H, Zhang SD, Han TQ, Eriksson M, Parini P (2010) HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver. J Lipid Res 51(6):1354\u20131362","journal-title":"J Lipid Res"},{"issue":"3","key":"931_CR46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/JOE-09-0271","volume":"204","author":"C Zhao","year":"2010","unstructured":"Zhao C, Dahlman-Wright K (2010) Liver X receptor in cholesterol metabolism. J Endocrinol 204(3):233\u2013240","journal-title":"J Endocrinol"},{"issue":"5936","key":"931_CR47","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","volume":"325","author":"N Zelcer","year":"2009","unstructured":"Zelcer N, Hong C, Boyadjian R, Tontonoz P (2009) LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325(5936):100\u2013104","journal-title":"Science"},{"issue":"3","key":"931_CR48","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/me.2002-0246","volume":"17","author":"B Goodwin","year":"2003","unstructured":"Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA (2003) Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol Endocrinol 17(3):386\u2013394","journal-title":"Mol Endocrinol"},{"issue":"8","key":"931_CR49","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/ATVBAHA.109.191197","volume":"30","author":"AC Calkin","year":"2010","unstructured":"Calkin AC, Tontonoz P (2010) Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol 30(8):1513\u20131518","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"931_CR50","first-page":"519","volume":"21","author":"M Parikh","year":"2014","unstructured":"Parikh M, Patel K, Soni S, Gandhi T (2014) Liver X receptor: a cardinal target for atherosclerosis and beyond. J Atheroscler Thromb 21(6):519\u2013531","journal-title":"J Atheroscler Thromb"},{"issue":"9","key":"931_CR51","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/db07-0056","volume":"56","author":"M Hao","year":"2007","unstructured":"Hao M, Head WS, Gunawardana SC, Hasty AH, Piston DW (2007) Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes 56(9):2328\u20132338","journal-title":"Diabetes"},{"issue":"3","key":"931_CR52","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0005-2760(86)90054-8","volume":"876","author":"JM Hoeg","year":"1986","unstructured":"Hoeg JM, Edge SB, Demosky SJ Jr, Starzl TE, Triche T, Gregg RE, Brewer HB Jr (1986) Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects. Biochim Biophys Acta 876(3):646\u2013657","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"931_CR53","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1194\/jlr.M600439-JLR200","volume":"48","author":"DE Telford","year":"2007","unstructured":"Telford DE, Sutherland BG, Edwards JY, Andrews JD, Barrett PH, Huff MW (2007) The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin. J Lipid Res 48(3):699\u2013708","journal-title":"J Lipid Res"},{"issue":"1","key":"931_CR54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1254\/jphs.10241FP","volume":"116","author":"T Maejima","year":"2011","unstructured":"Maejima T, Sugano T, Yamazaki H, Yoshinaka Y, Doi T, Tanabe S, Nishimaki-Mogami T (2011) Pitavastatin increases ABCA expression by dual mechanisms: SREBP2-driven transcriptional activation and PPAR\u03b1-dependent protein stabilization but without activating LXR in rat hepatoma McARH7777 cells. J Pharmacol Sci 116(1):107\u2013115","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"931_CR55","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.gene.2012.02.031","volume":"499","author":"M Soufi","year":"2012","unstructured":"Soufi M, Ruppert V, Kurt B, Schaefer JR (2012) The impact of severe LDL receptor mutations on SREBP-pathway regulation in homozygous familial hypercholesterolemia (FH). Gene 499(1):218\u2013222","journal-title":"Gene"},{"issue":"3","key":"931_CR56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0014-5793(01)03007-1","volume":"507","author":"LH Chamberlain","year":"2001","unstructured":"Chamberlain LH (2001) Inhibition of isoprenoid biosynthesis causes insulin resistance in 3 T3-L1 adipocytes. FEBS Lett 507(3):357\u2013361","journal-title":"FEBS Lett"},{"issue":"S1994A","key":"931_CR57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jcb.240550007","volume":"55","author":"FM Ashcroft","year":"1994","unstructured":"Ashcroft FM, Proks P, Smith PA et al (1994) Stimulus\u2013secretion coupling in pancreatic \u03b2 cells. J Cell Biochem 55(S1994A):54\u201365","journal-title":"J Cell Biochem"},{"issue":"6","key":"931_CR58","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2014.02.014","volume":"63","author":"M Brault","year":"2014","unstructured":"Brault M, Ray J, Gomez YH, Mantzoros CS, Daskalopoulou SS (2014) Statin treatment and new-onset diabetes: a review of proposed mechanisms. Metabolism 63(6):735\u2013745","journal-title":"Metabolism"},{"issue":"2","key":"931_CR59","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.atherosclerosis.2015.06.001","volume":"241","author":"AJ Vallejo-Vaz","year":"2015","unstructured":"Vallejo-Vaz AJ, Kondapally Seshasai SR, Kurogi K, Michishita I, Nozue T, Sugiyama S, Tsimikas S, Yoshida H, Ray KK (2015) Effect of pitavastatin on glucose, HbA1c and incident diabetes: a meta-analysis of randomized controlled clinical trials in individuals without diabetes. Atherosclerosis 241(2):409\u2013418","journal-title":"Atherosclerosis"},{"key":"931_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1567-5688(14)70002-9","volume":"16","author":"L Arnaboldi","year":"2015","unstructured":"Arnaboldi L, Corsini A (2015) Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin. Atheroscler Suppl 16:1\u201327","journal-title":"Atheroscler Suppl"},{"issue":"2","key":"931_CR61","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jacl.2015.11.015","volume":"10","author":"F Barkas","year":"2016","unstructured":"Barkas F, Elisaf M, Liberopoulos E, Klouras E, Liamis G, Rizos EC (2016) Statin therapy with or without ezetimibe and the progression to diabetes. J Clin Lipidol 10(2):306\u2013313","journal-title":"J Clin Lipidol"},{"issue":"6","key":"931_CR62","doi-asserted-by":"crossref","first-page":"G1170","DOI":"10.1152\/ajpgi.00402.2005","volume":"290","author":"X Lin","year":"2006","unstructured":"Lin X, Chen Z, Yue P, Averna MR, Ostlund RE Jr, Watson MA, Schonfeld G (2006) A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation. Am J Physiol Gastrointest Liver Physiol 290(6):G1170\u2013G1176","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"931_CR63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.aje.a115479","volume":"131","author":"TA Miettinen","year":"1990","unstructured":"Miettinen TA, Tilvis RS, Kes\u00e4niemi YA (1990) Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 131(1):20\u201331","journal-title":"Am J Epidemiol"},{"issue":"10","key":"931_CR64","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.numecd.2011.05.005","volume":"21","author":"TA Miettinen","year":"2011","unstructured":"Miettinen TA, Gylling H, Nissinen MJ (2011) The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr Metab Cardiovasc Dis 21(10):765\u2013769","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"931_CR65","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0022-2275(20)38603-X","volume":"28","author":"I Bj\u00f6rkhem","year":"1987","unstructured":"Bj\u00f6rkhem I, Miettinen T, Reihn\u00e9r E, Ewerth S, Angelin B, Einarsson K (1987) Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 28(10):1137\u20131143","journal-title":"J Lipid Res"},{"issue":"2","key":"931_CR66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.atherosclerosis.2010.10.050","volume":"216","author":"D Noto","year":"2011","unstructured":"Noto D, Cefal\u00f9 AB, Barraco G, Fayer F, Min\u00e0 M, Yue P, Tarugi P, Schonfeld G, Averna MR (2011) Plasma non-cholesterol sterols in primary hypobetalipoproteinemia. Atherosclerosis 216(2):409\u2013413","journal-title":"Atherosclerosis"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-016-0931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-016-0931-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-016-0931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T23:51:48Z","timestamp":1657583508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-016-0931-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,2]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["931"],"URL":"https:\/\/doi.org\/10.1007\/s00592-016-0931-4","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,2]]}}}